Time to really share real-world data?
- PMID: 30364186
- PMCID: PMC6192440
- DOI: 10.12688/f1000research.15517.1
Time to really share real-world data?
Abstract
Data other than that from clinical trials are important for healthcare decision making. However, unlike the vocal calls seen for more open access to trial data, there are limited efforts being made to ensure that agencies that collect real-world data (RWD) share this, despite its importance. There are many RWD sources across the world that could be readily exploited for research once shared. There are policy and privacy questions that need to be tackled, but opening up and sharing RWD offers remarkable potential for improvements in care for individuals and more effective use of limited healthcare resources. Open science should become the standard for RWD as well as clinical trials, especially those that have a high likelihood to influence practice.
Keywords: clinical data; real-world data; sharing.
Conflict of interest statement
Competing interests: SG and RW are employees of Evidera. LM, ML and SR are employees of Bristol-Myers Squibb.
References
-
- Guinney J, Wang T, Laajala TD, et al. : Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data. Lancet Oncol. 2017;18(1):132–142. 10.1016/S1470-2045(16)30560-5 - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
